A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
Status:
Active, not recruiting
Trial end date:
2022-02-16
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about how tirzepatide affects the body's
response to low blood sugar (hypoglycemia). The study is open to participants with type 2
diabetes. It will last about 42 weeks for each participant.